ProCE Banner Activity

Applying New European Guideline Updates in AML: Experts Review Current Best Practice in Treatment and Molecular Testing—Italy

Multimedia
Learn more about the latest guideline updates on AML and how those changes are poised to impact practice in this webcast from the first of 2 expert roundtables.

Released: November 30, 2022

Expiration: November 29, 2023

No longer available for credit.

Share

Faculty

Claudio Cerchione

Claudio Cerchione, MD, PhD

Romagnolo Institute for the Study of Tumors "Dino Amadori"
Hematology Unit
Medical Director/Researcher
Hematology Unit
Istituto Romagnolo per Lo Studio dei Tumori "Dino Amadori" - IRST IRCCS
Meldola, Italy

Naval G. Daver

Naval G. Daver, MD

Associate Professor
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

Adolfo de la Fuente Burguera

Adolfo de la Fuente Burguera, MD

Head of Hematology Department
MD Anderson CC Madrid
Madrid, Spain

Courtney DiNardo

Courtney DiNardo, MD, MSCE

Professor of Medicine
Department of Leukemia
MD Anderson Cancer Center
Houston, Texas

Giovanni Martinelli

Giovanni Martinelli, MD

Associate Professor
Institute of Hematology "L. and A. Seràgnoli"
Alma Mater Studiorum
University of Bologna
Bologna, Italy
Scientific Director
Department of Hematology
IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"- IRST S.r.l.
Meldola, Italy

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Servier Pharmaceuticals

Program Director Disclosure

Program Director

Claudio Cerchione, MD, PhD

Romagnolo Institute for the Study of Tumors "Dino Amadori"
Hematology Unit
Medical Director/Researcher
Hematology Unit
Istituto Romagnolo per Lo Studio dei Tumori "Dino Amadori" - IRST IRCCS
Meldola, Italy

Claudio Cerchione, MD, PhD: consultant/advisor/speaker: Glycomimetics, Menarini/Stemline.

Faculty Disclosure

Primary Author

Naval G. Daver, MD

Associate Professor
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, Texas

Naval G. Daver, MD: researcher: AbbVie, Amgen, Astellas, Bristol-Myers Squibb, Daiichi Sankyo, FATE Therapeutics, Genentech, Gilead, Glycomimetics, Hanmi, ImmunoGen, Novimmune, Pfizer, Servier, Trillium, Trovagene; consultant/advisor/speaker: AbbVie, Agios, Astellas, Amgen, Arog, Bristol-Myers Squibb, Celgene, Daiichi Sankyo, Genentech, Gilead, Jazz, Novartis, Pfizer, Servier, Shattuck Labs, Syndax, Trillium; independent contractor: ImmunoGen.

Adolfo de la Fuente Burguera, MD

Head of Hematology Department
MD Anderson CC Madrid
Madrid, Spain

Adolfo de la Fuente Burguera, MD: speaker: AbbVie, Celgene/Bristol-Myers Squibb, Daiichi Sankyo, Incyte, Janssen-Cilag, Jazz, Novartis, Pfizer, Roche; advisor: AbbVie, Astellas, Celgene/Bristol-Myers Squibb, Daiichi Sankyo, Incyte, Jazz, Mundipharma, Pfizer, Roche; researcher: BTG, Janssen-Cilag, Novartis.

Courtney DiNardo, MD, MSCE

Professor of Medicine
Department of Leukemia
MD Anderson Cancer Center
Houston, Texas

Courtney DiNardo, MD, MSCE: consultant/advisor/speaker: AbbVie, Astellas, Bristol-Myers Squibb, Genmab, GlaxoSmithKline, Jazz, Novartis, Servier.

Giovanni Martinelli, MD

Associate Professor
Institute of Hematology "L. and A. Seràgnoli"
Alma Mater Studiorum
University of Bologna
Bologna, Italy
Scientific Director
Department of Hematology
IRCCS Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori"- IRST S.r.l.
Meldola, Italy

Giovanni Martinelli, MD, has no relevant financial relationships to disclose.